Skip To The Main Content

Press Releases

U.S. FDA Deputy Commissioner Dr. Robert Califf to give 2015 PDA/FDA Jt. Regulatory Conf. Keynote Talk

For Immediate Release:
Media Inquiries:
Walt Morris
/ [email protected] /
301-656-5900, x. 148

Bethesda, Md., May 14, 2015 – The Parenteral Drug Association (PDA) today is pleased to announce that Robert Califf, MD, U.S. FDA Deputy Commissioner of the Office of Medical Products and Tobacco will deliver the keynote address at the 2015 PDA/FDA Joint Regulatory Conference, September 28-30, Washington, DC.

Dr. Califf will make his remarks during the opening plenary session, which will include presentations on innovative manufacturing and regulatory solutions for patient care in a crisis. New tools have been given to the Agency to improve the quality of drugs through the FDA Safety and Innovation Act, the Drug Quality and Safety Act and the Generic Drug User Fee Act. The Center of Disease Control’s Sr. Medical Officer Joseph Woodring will speak in the same session.

"The PDA/FDA Joint Regulatory Conference is well-known for the participation of high-level officials from the U.S. FDA and its sister-agencies within the Department of Health and Human Services," said PDA President Richard Johnson. "Every year, PDA’s efforts to connect people, science and regulation lead to the participation of over 50 officials from regulatory bodies in this conference both as speakers and attendees. It is one of the best opportunities for PDA’s members to get the latest updates on regulatory policy and compliance trends."

The 2015 PDA/FDA Joint Regulatory Conference will be simultaneously translated into Japanese for the benefit of PDA’s more than 920 members in Japan.

The 2015 meeting once again will be held at the Renaissance Washington DC Hotel. Members of the press are encouraged to attend. Go to to request a press pass.

About the PDA/FDA Joint Regulatory Conference

For over 30 years the PDA/FDA JRC has been connecting drug manufacturers with the U.S. FDA. This year’s theme is "Mission Possible: Patient-Focused Manufacturing, Quality and Regulatory Solutions." For more information, go to